![]() |
Understanding the Stages of Breast Cancer
|
![]() |
The Pros and Cons of Breast Cancer Adjuvant Therapy
|
![]() |
Using Aromatase Inhibitors in Early Stage Breast Cancer
|
![]() |
Breast Cancer Genetics
|
![]() |
Hormonal Therapy for Breast Cancer: Assessing Benefits and Side Effects
|
![]() |
Breast Cancer: What is Your Risk?
|
![]() |
How to Succeed With Breast Cancer Adjuvant Therapy
|
![]() |
A Good Doctor-Patient Relationship in Breast Cancer
|
![]() |
Anthracyclines in Adjuvant Breast Cancer Therapy: Survival Benefits
|
![]() |
Hormonal Therapy for Breast Cancer: New Options
|
![]() |
New Technologies in Breast Cancer: Breast Ultrasound
|
![]() |
What is Hormone Receptor Positive Breast Cancer?
|
![]() |
Anthracyclines for Breast Cancer: Does Stage Matter?
|
![]() |
Bone Complications in Breast Cancer
|
![]() |
Interpreting Mammograms
|
![]() |
Which Adjuvant Therapy is Right for Your Breast Cancer?
|
![]() |
Preventing Breast Cancer Recurrence: What's Right for Me?
|
![]() |
Technologies in Breast Cancer: Breast MRI
|
![]() |
Breast Cancer Trials: How Have They Changed Breast Cancer Therapy?
|
![]() |
Advice To Women Newly Diagnosed With Breast Cancer
|
![]() |
Technologies in Breast Cancer: Digital Mammography
|
![]() |
A New Voice in Breast Cancer Activism: Soraya's Story
|
![]() |
Breast Cancer Detection
|
![]() |
Better Breast Cancer Therapy: Making Anthracyclines More Effective
|
![]() |
Hormone Replacement Therapy vs. Hormonal Treatment: What's the Difference?
|
![]() |
Living with Breast Cancer Treatments: Personal Stories
|
![]() |
Preparing For Side Effects: What to Expect From Breast Cancer Therapies
|
![]() |
Technologies in Breast Cancer: Positron Emission Tomography
|
![]() |
Understanding Hormonal Therapy for Early Stage Breast Cancer
|
![]() |
Hormonal Therapy for Breast Cancer: Current Issues
|
![]() |
Talking to Your Doctor About Early-Stage Breast Cancer
|
Breast cancer is the abnormal growth and uncontrolled division of cells in the breast. Cancer cells can invade and destroy surrounding tissue, and may metastasize
Breast cancer is a leading cause of morbidity (illness) and mortality (death) for women. It is the second most common cause of cancer death among American women; every year, about 180,000 women are diagnosed with the disease.
Every woman is at risk for breast cancer. If a woman lives to age 85, there is one chance in nine that she will develop the condition sometime during the rest of her life. Age is an established risk factor; the risk of developing the disease increases with advancing age. The breast cancer risk of a 25-year-old woman is only one out of 19,608; by age 45, it is one in 93. More than 75% of all breast cancers are detected in women over age 50.
There are a number of risk factors for the development of breast cancer, including:
More than 75% of all breast cancers are diagnosed in women without a family history or other major risk factor for the disease. Inherited gene alterations also place women at risk for developing breast cancer at younger ages. About 20% of cases occur in families with a history of breast cancer. A breast cancer gene was discovered in 1994, however, only about 5% of breast cancers are believed to be related to the gene.
Some studies suggest that high fat diets, obesity, radiation exposure, or alcohol consumption contribute to the risk profile. Researchers have found that for certain women, hormone replacement therapy may contribute to the development of breast cancer. While one or more risk factors may boost a woman's chances of developing breast cancer, the interplay of factors is complex.
Not all lumps detected in the breast are malignant (cancerous). Many are benign and may be related to other breast diseases such as fibrocystic breast disease and require no treatment or simply the removal of the lump. All women should be taught to perform regular, monthly breast self-examinations (BSE) to detect any
changes in breast tissue. Health professionals should also encourage women to schedule a screening mammography, which is a breast x ray that will detect cysts or tumors too small to be found during self-examination.
Changes in the breast that may be a sign of breast cancer include:
More than 90% of all breast cancers are detected by mammography. The American Cancer Society guidelines recommend screening mammograms every one to two years for women between 40 and 49, and every year after age 50. Women with a family history of breast cancer will be advised to have a mammogram every year at an earlier age.
Typically, mammography screening includes two views of each breast, one from above, and one from the side. Generally, the radiology technician examines the images immediately to make sure no further x rays are needed, or to decide whether an ultrasound may be required.
If an irregularity is detected, such as a mass, changes from earlier mammograms, abnormalities of the skin, or enlargement of the lymph nodes, further testing may be recommended. Diagnostic testing may include ultra- sound of the breast, a biopsy, or needle sampling, or consultation with a breast surgeon.
Biopsy of the breast is a removal of breast tissue for examination by a pathologist. An excisional biopsy is a surgical procedure in which the entire lump area and a margin of surrounding tissue are removed for examination. If the mass is very large, an incisional biopsy is performed to remove a portion of the suspicious area. Needle biopsy may be performed using two different methods. An aspiration needle biopsy uses a very fine needle to withdraw cells and fluid from the mass for analysis. A large core needle biopsy uses a larger diameter needle to remove small pieces of tissue from the mass that can be analyzed. These analyses determine whether the mass is benign or cancerous and whether further treatment is required.
To determine if the cancer has metastasized, physicians remove some axillary (underarm) lymph nodes to examine them for the presence of cancer cells. Lymph node dissection, the procedure that determines whether cancer cells are in the lymph nodes, is part of the process of staging (classifying the extent) the cancer. Breast cancer is rated from Stage 0 to Stage IV. The staging process uses an array diagnostic information to describe the extent of disease and includes:
|
|
Author Info: Barbara Wexler, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Nursing and Allied Health, 2002 |